Continuous Glucose Monitoring Systems Can Meet the Challenge of Glucose Management and Beyond in Individuals with Type 2 Diabetes: An Expert Multidisciplinary Position
Abstract
The increasing prevalence of type 2 diabetes (T2D) can be considered a global healthcare emergency, with far-reaching burdens on the health and well-being of people with diabetes, their carers and families, and the mounting costs within each national healthcare economy. Although application of diabetes technologies, such as insulin pumps, continuous glucose monitoring (CGM) systems, and a range of connected devices, is starting to have an impact on the outcomes of care for people with type 1 diabetes (T1D), similar application for people with T2D is lagging behind. This is a purely cost-based decision, since evidence from numerous randomized controlled trials (RCTs) and real-world studies has shown the significant clinical impact of diabetes technologies for people with T2D, whether they are on insulin therapy or not. Amongst available technologies, it is the lack of widespread access to CGM devices for people with T2D that is most pressing, as these systems have the potential to bring a quantum change in the way people with T2D and their healthcare professionals (HCPs) are supported to manage the adverse impact both of hyperglycemia and hypoglycemia. Central to improving diabetes care for people with T2D is the demonstration in many studies that CGM can actively support healthy behavioral changes to meal planning and physical activity, with concomitant improvements in mental health and quality of life. In this expert opinion, we review the significant evidence base on which…
Read the paper
Related studies
- Quantum dots: synthesis, bioapplications, and toxicity
- A Guide to In Silico Drug Design
- Quantum Computing for Healthcare: A Review
- Automated in Silico Design of Homogeneous Catalysts
- Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach
- In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.